|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 37/06 | |||
| A61P 1/00 | |||
| A61P 19/02 | |||
| A61P 11/06 | |||
| A61P 11/00 | |||
| A61P 37/00 | |||
| C07K 16/28 | |||
| C07K 16/18 |
| (11) | Patento numeris | 1830881 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05856275.2 |
| Europos patento paraiškos padavimo data | 2005-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-06-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2005/004174 |
| Data | 2005-12-12 |
| (87) | Numeris | WO 2006/077471 |
| Data | 2006-07-27 |
| (30) | Numeris | Data | Šalis |
| 635421 P | 2004-12-10 | US |
| (72) |
ELSON, Greg, FR
LEGER, Olivier, FR
|
| (73) |
Novimmune SA,
64 Avenue de la Roseraie, 1211 Genčve,
CH
|
| (54) | COMBINING THERAPIES TARGETING MULTIPLE TOLL-LIKE RECEPTORS AND USE THEREOF |
| COMBINING THERAPIES TARGETING MULTIPLE TOLL-LIKE RECEPTORS AND USE THEREOF |